Pearl Toy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pearl Toy has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Clifford A. Lowell
Department of Laboratory Medicine, UCSF, San Francisco, United States of America
1 shared publication Jason Jun
From the Blood Bank, Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California
1 shared publicationK.M. Hollis‐Perry
From the Blood Bank, Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California
1 shared publicationMayumi Nakagawa
From the Blood Bank, Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California
1 shared publicationOgnjen Gajic
1 shared publication
Latest Publications
- 1 June 2007
- Published by Elsevier in Best Practice & Research Clinical Anaesthesiology
- Vol. 21 (2) , 183-193
TRALI – Definition, mechanisms, incidence and clinical relevance
- 1 June 2007
- Published by Elsevier in Best Practice & Research Clinical Anaesthesiology
- Vol. 21 (2) , 183-193
TRALI – Definition, mechanisms, incidence and clinical relevance
- 2 December 2004
- Published by Wiley in Transfusion
- Vol. 44 (12) , 1683-1688
Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion‐related acute lung injury
BACKGROUND: The effects of transfusion of HLA antibodies to patients with corresponding antigens are not well known.STUDY DESIGN AND METHODS: Records of patients who received blood from previous donations of a donor implicated in a case of transfusion‐related acute lung injury (TRALI) were examined. The donor had multiple HLA antibodies reactive with 96 percent of HLA Class I antigens and 88 percent of HLA Class II antigens.RESULTS: Among 103 patients (40 with a pretransfusion white blood cell [WBC] count of ≥3.5 × 109/L), 1 patient met criteria for TRALI and had clinical evidence for diffuse alveolar hemorrhage. Among the subset of 55 patients (17 with a pretransfusion WBC count of 3.5 × 109/L) with known HLA types, none developed TRALI even though 54 (98%) had one to five corresponding HLA antigens. In a subgroup of patients four of 62 patients with chest radiographs, developed new or worse bilateral infiltrates with implicated but not control units (p = 0.0625).CONCLUSION: Transfusion of HLA antibodies from this donor to nonneutropenic patients did not cause TRALI, but there was a trend of an association with new or worse bilateral pulmonary infiltrates. Further research is needed to determine why transfusion of HLA antibodies to recipients with corresponding antigens causes TRALI in some cases and not in others.
- 2 December 2004
- Published by Wiley in Transfusion
- Vol. 44 (12) , 1683-1688
Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion‐related acute lung injury
BACKGROUND: The effects of transfusion of HLA antibodies to patients with corresponding antigens are not well known.STUDY DESIGN AND METHODS: Records of patients who received blood from previous donations of a donor implicated in a case of transfusion‐related acute lung injury (TRALI) were examined. The donor had multiple HLA antibodies reactive with 96 percent of HLA Class I antigens and 88 percent of HLA Class II antigens.RESULTS: Among 103 patients (40 with a pretransfusion white blood cell [WBC] count of ≥3.5 × 109/L), 1 patient met criteria for TRALI and had clinical evidence for diffuse alveolar hemorrhage. Among the subset of 55 patients (17 with a pretransfusion WBC count of 3.5 × 109/L) with known HLA types, none developed TRALI even though 54 (98%) had one to five corresponding HLA antigens. In a subgroup of patients four of 62 patients with chest radiographs, developed new or worse bilateral infiltrates with implicated but not control units (p = 0.0625).CONCLUSION: Transfusion of HLA antibodies from this donor to nonneutropenic patients did not cause TRALI, but there was a trend of an association with new or worse bilateral pulmonary infiltrates. Further research is needed to determine why transfusion of HLA antibodies to recipients with corresponding antigens causes TRALI in some cases and not in others.
- 1 December 2004
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 99 (6) , 1623-1624
Transfusion-Related Acute Lung Injury
Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality. It is characterized by injury to the alveolar-capillary membrane precipitated by transfusion factors, antibodies, and/or inflammatory mediators, in a susceptible host. In the absence of a specific test, TRALI is defined clinically as a syndrome of acute lung injury that develops during or within 6 h of transfusion. The absence of left atrial hypertension and large protein content of edema fluid may help differentiate TRALI from hydrostatic pulmonary edema. The treatment is supportive. The blood bank needs to be notified promptly so that an appropriate workup and prevention are initiated in a timely manner.
- 1 December 2004
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 99 (6) , 1623-1624
Transfusion-Related Acute Lung Injury
Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality. It is characterized by injury to the alveolar-capillary membrane precipitated by transfusion factors, antibodies, and/or inflammatory mediators, in a susceptible host. In the absence of a specific test, TRALI is defined clinically as a syndrome of acute lung injury that develops during or within 6 h of transfusion. The absence of left atrial hypertension and large protein content of edema fluid may help differentiate TRALI from hydrostatic pulmonary edema. The treatment is supportive. The blood bank needs to be notified promptly so that an appropriate workup and prevention are initiated in a timely manner.